Ninfa Saunders
CIK: 0001815499
Transaction Breakdown
High conviction signal
Position reduction
Derivative conversions
Compensation grants
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
T2 Biosystems, Inc.
Discretionary Trading P&L
Holdings
Ninfa Saunders files insider reports with the SEC as Director of T2 Biosystems, Inc. (TTOO). Signal8 holds 1 reported Form 4/5 transaction by Ninfa Saunders since Sep 2024. The most recent reported transaction is a grant / award (Form 4 code A) in TTOO, dated Nov 4, 2024.
About Saunders Ninfa
Saunders Ninfa (SEC CIK 0001815499) files insider reports with the SEC as Director of T2 Biosystems, Inc. (TTOO).
Signal8 holds 1 ownership filing by Saunders Ninfa, a Form 4, filed on Jan 2, 2025. Those filings report 1 transaction, the latest on Nov 4, 2024. Signal8's Form 4 history starts in Sep 2024.
The business address on Saunders Ninfa's filings is in LEXINGTON, MA.
Recent filings by Saunders Ninfa
- Nov 4, 2024: Grant or award of TTOO derivative securities (Form 4, code A).
Other insiders filing for T2 Biosystems, Inc. (TTOO)
- LIEBMAN SEYMOUR, Director
- Giffin Brett A., Chief Commercial Officer
- Adams Laura Lee, Director
- CUMMING JOHN W, Director
- Gibbs Michael Terrence, General Counsel
- Toft Robin, Director